Single-use technology propelling upstream bioprocessing market expansion
European Pharmaceutical Review
FEBRUARY 20, 2024
million by 2029. percent between 2022 and 2029. The rising productivity of cell lines has improved the performance of upstream processing with low cost and high process reproducibility, the report explained. Additionally, the research calculated that market is anticipated to undergo a CAGR of 6.85
98 
Let's personalize your content